1. Introduction {#sec1-antibiotics-09-00029}
===============

Urinary tract infections (UTIs) are ones of the main hospital- and community-acquired bacterial infections \[[@B1-antibiotics-09-00029]\]. *Escherichia coli,* the microorganism that is the most frequent cause of UTIs, has become resistant to many available antibiotics, including third generation cephalosporins, carbapenems and colistin \[[@B1-antibiotics-09-00029],[@B2-antibiotics-09-00029]\]. Infections caused by multidrug-resistant (MDR) bacteria have become a major healthcare problem worldwide \[[@B3-antibiotics-09-00029],[@B4-antibiotics-09-00029]\]. Currently, there is a great need to search for new, natural molecules that have antibacterial effects and that can act against these MDR strains. Essential oils (EOs), also known as volatile oils, are one of the main natural bioactive substances extracted from plants, and have been used as alternative medicines, especially as antimicrobial agents \[[@B5-antibiotics-09-00029]\]. Among them, the EOs obtained from the genus *Origanum* L. have attracted the attention of microbiologists due to their widespread use as natural food preserving agents \[[@B6-antibiotics-09-00029]\].

*O. glandulosum* Desf. (synonymous with *O*. *vulgare* subsp. *glandulosum* (Desf.) Ietswaart) is a member of the *Lamiaceae* family and an endemic plant in two African-Mediterranean countries, namely, Algeria and Tunisia \[[@B7-antibiotics-09-00029],[@B8-antibiotics-09-00029]\]. Local populations use this plant for its medicinal properties to treat different diseases such as cough, fever and bronchitis \[[@B8-antibiotics-09-00029]\]. Several studies have reported the chemical composition of Algerian \[[@B7-antibiotics-09-00029],[@B8-antibiotics-09-00029],[@B9-antibiotics-09-00029],[@B10-antibiotics-09-00029],[@B11-antibiotics-09-00029],[@B12-antibiotics-09-00029]\] and Tunisian \[[@B13-antibiotics-09-00029],[@B14-antibiotics-09-00029]\] *O. glandulosum* EOs and showed that thymol, carvacrol, *γ*-terpinene and *p*-cymene were the main components. However, the antibacterial properties of *O. glandulosum* EOs have only been examined in a few studies, mainly, against reference strains of the American Type Culture Collection (ATCC) \[[@B7-antibiotics-09-00029],[@B14-antibiotics-09-00029],[@B15-antibiotics-09-00029]\]. To the best of our knowledge, there have been no reports on the antibacterial properties of *O. glandulosum* EOs against MDR-uropathogenic *E. coli* strains. Thus, the aims of this study were: (i) to determine the chemical composition of EOs extracted from five different populations of *O. glandulosum* growing in Algeria, and (ii) to investigate the potential antibacterial activity of these EOs against MDR-uropathogenic *E. coli* strains.

2. Results {#sec2-antibiotics-09-00029}
==========

2.1. Yield and Chemical Composition of the Essential Oils {#sec2dot1-antibiotics-09-00029}
---------------------------------------------------------

The obtained EO yields were 3.9, 5.6, 4.1, 1.8 and 2.8% (w/w) for accessions from Sétif, Mila, Bordj, M'sila and El Oued, respectively. As shown in [Table 1](#antibiotics-09-00029-t001){ref-type="table"}, the gas chromatography/mass spectrometry (GC/MS) analysis identified 43 (EO from M'sila), 37 (EO from Sétif), 37 (EO from Bordj), 34 (EO from Mila) and 21 (EO from El Oued) components, respectively, which accounted for 99.8--100% of the total composition of the EOs. For all the EOs, the four main detected components were thymol (15.1--56.3%), carvacrol (2.8--59.6%), *γ*-terpinene (9.8--21.8%) and *p*-cymene (8.5--13.9%). Thymol was predominant in EOs from Sétif (56.3%), Mila (51.0%) and M'sila (40.1%), while carvacrol was the major component in EOs from Bordj (59.6%) and El Oued (45.1%).

2.2. Antibacterial Activity {#sec2dot2-antibiotics-09-00029}
---------------------------

The disc diffusion, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) results ([Table 2](#antibiotics-09-00029-t002){ref-type="table"} and [Table 3](#antibiotics-09-00029-t003){ref-type="table"}) showed that all the EOs exhibited good antibacterial activity against both reference (*E. coli* ATCC 25922 and *E. coli* J53) and MDR *E. coli* strains. The MDR *E. coli* 229, *E. coli* 667 and *E. coli* 115 strains were less susceptible than the other strains, while the standard *E. coli* ATCC 25922 strain was the most susceptible. When the EOs were diluted at 1/2, the inhibition zones of all the EOs were ≥23 mm, while the positive control gentamycin (disc charge = 15 µg) was less effective, and there were no inhibition zones against some strains or halos produced with diameters \< 23 mm. Carvacrol and thymol were the most active components, and showed good antibacterial activity (the MIC/MBC ranged from 0.25 to 0.5 mg/mL) ([Table 2](#antibiotics-09-00029-t002){ref-type="table"} and [Table 3](#antibiotics-09-00029-t003){ref-type="table"}). *p*-Cymene was less active (inhibition zone diameters between 10 and 12.5 mm at a dilution of 1/2 and MIC/MBC \> 2 mg/mL), while *γ*-terpinene was totally inactive against all the strains ([Table 2](#antibiotics-09-00029-t002){ref-type="table"}). Combinations of *p*-cymene + carvacrol and *p*-cymene + thymol showed very similar results (inhibition zone diameters between 28 and 32 mm).

3. Discussion {#sec3-antibiotics-09-00029}
=============

In this study, we investigated the chemical composition and the antibacterial activity of *O. glandulosum* EOs obtained from five different Algerian locations. The five EOs shared a similar qualitative composition, which was mainly characterized by four major components (thymol, carvacrol, *γ*-terpinene and *p*-cymene). Our findings were qualitatively in agreement with those reported in the literature \[[@B7-antibiotics-09-00029],[@B8-antibiotics-09-00029],[@B9-antibiotics-09-00029],[@B10-antibiotics-09-00029]\]. However, the composition of our five EOs differed quantitatively. Thymol was the major component in three EOs (Sétif, Mila, M'sila), while carvacrol was predominant in the two remaining ones (Bordj, El Oued). Several studies have reported that carvacrol \[[@B7-antibiotics-09-00029],[@B8-antibiotics-09-00029],[@B9-antibiotics-09-00029],[@B10-antibiotics-09-00029],[@B14-antibiotics-09-00029]\] was the major component in *O. glandulosum* EOs, while other studies on the chemical composition of *O. glandulosum* EOs collected from other localities, showed that thymol was the predominant component \[[@B7-antibiotics-09-00029],[@B10-antibiotics-09-00029],[@B15-antibiotics-09-00029]\]. In another study, Khalfi et al. \[[@B12-antibiotics-09-00029]\] reported comparable amounts of both compounds (thymol 38.8% and carvacrol 32.9%). Conversely, Mechergui et al. \[[@B13-antibiotics-09-00029]\] found that *p*-cymene (36%, 40% and 46%) followed by thymol (32%, 39% and 18%) were the major components detected in *O. glandulosum* EOs obtained from three localities (Nefza, Bargou and Krib, respectively) in the north of Tunisia.

Although all the previous studies (including our study) involved the same plant species (*O. glandulosum*), we observed differences in the chemical composition, especially in the quantity of the main EO components. This might be due to variations in many factors that affect the investigated accessions, such as climate and temperature, type of soil, relief, period of plant collection and the part of the plant (e.g., leaves, stems and flowers) \[[@B16-antibiotics-09-00029]\]. In our study, all the five accessions were collected during the same period. Moreover, the same parts of plants were used to obtain the EOs. However, with regard to the climate, the M'sila and El-Oued areas are characterized by high temperatures and low precipitation rates whereas Sétif and Mila are located in rocky regions and at higher altitude.

The evaluation of the antibacterial activity of the five EOs against six uropathogenic MDR and two standard *E. coli* strains revealed that all the five EOs were active against all the tested strains, showing similar inhibition zone diameters as well as MIC and MBC values. The EO from Bordj contained the highest amount of carvacrol (59.6%) and showed the highest antibacterial activity (diameters from 12 to 24.5 mm at dilution of 1/10). To our knowledge, this is the first description of the antibacterial properties of *O. glandulosum* EOs against MDR uropathogenic *E. coli* strains. Béjaoui et al. \[[@B14-antibiotics-09-00029]\] reported the good activity of Tunisian *O. glandulosum* EOs tested at different phenological stages against a standard *E. coli* strain (*E. coli* ATCC 8739). Similar results (good growth inhibition) were also obtained when testing different Algerian *O. glandulosum* EOs against *E. coli* ATCC 25922 (standard strain) \[[@B7-antibiotics-09-00029]\] and three other clinical strains (E~1~, E~2~ and E~3~) \[[@B9-antibiotics-09-00029]\].

EOs containing high amounts of phenolic monoterpenes, such as carvacrol and thymol are widely reported to have remarkable antibacterial properties \[[@B17-antibiotics-09-00029]\]. These compounds are capable of aligning between the fatty acid chains to form a sort of channel through the membrane, and are able to interact with transmembrane proteins, thus affecting the microbial cell permeability. They also exert detrimental effects on the outer membrane of Gram-negative bacteria \[[@B18-antibiotics-09-00029]\]. Another important microbial effect reported for these phenolic monoterpenes is their interference with the ATP generation system \[[@B18-antibiotics-09-00029]\].

Since our five EOs were rich in thymol and/or carvacrol, we suggest that the obtained antibacterial activities were related to the high concentration of these two constituents. It is assumed that these compounds act by damaging the structure and function of the cytoplasmic membrane \[[@B19-antibiotics-09-00029]\]. However, it has also been reported that the antibacterial activity of EOs could be affected by other minor components, together with a possible interaction between different compounds \[[@B14-antibiotics-09-00029]\]. For example, *p*-cymene may synergize the efficacy of phenolic monoterpenes such as thymol and carvacrol \[[@B20-antibiotics-09-00029]\]. *p*-Cymene is highly hydrophobic and causes swelling of the cytoplasmic membrane, thus facilitating the transport of effective active compounds across the lipid bilayer. Our results counteract previous reports on the antibacterial activity of *p*-cymene \[[@B20-antibiotics-09-00029]\], proving that it is an effective agent against uropathogenic MDR strains, and could possibly be used in synergistic blends together with phenolic monoterpenes. These are relatively cheap, available on the market and easy to prepare, thus making it possible to produce formulations against multidrug-resistant uropathogenic *E. coli* strains where cultivation of *O. glandulosum* and production of its EOs is not feasible.

4. Materials and Methods {#sec4-antibiotics-09-00029}
========================

4.1. Plant Material {#sec4dot1-antibiotics-09-00029}
-------------------

The *O. glandulosum* Desf. samples were collected on June 2018 from 5 different locations situated in the east and southeast of Algeria: Chirhom (Sétif city), Sidi Aissa (M'sila city), Ras El oued (Bordj-Boarriridj city), Bouslah (Mila city) and Ben Guecha (El Oued city). The plants were identified by Prof. Laouar Hocine, University of Sétif-1, Algeria and confirmed by Prof. Filippo Maggi.

4.2. Essential Oil Extraction {#sec4dot2-antibiotics-09-00029}
-----------------------------

The air-dried aerial parts (stems, leaves, and flowers) of *O. glandulosum* Desf. were submitted to hydrodistillation for 3 h using a Clevenger-type apparatus. The obtained EOs were collected in amber glass vials and stored at 4 °C until used for analysis.

4.3. GC/MS Analysis {#sec4dot3-antibiotics-09-00029}
-------------------

The chemical analysis of the different EOs was carried out using an Agilent 6890 N gas chromatograph, coupled with a 5973 N mass spectrometer, operating in the EI mode at 70 eV, using a HP-5MS capillary column (5% phenylmethylpolysiloxane, 30 m, 0.25 mm i.d., 0.1 μm film thickness) (J & W Scientific, Folsom, CA, USA). The temperature schedule that was applied for this analysis was as follows: 60 °C for 5 min, followed by a 4 °C/min ramp to 220 °C, then 11 °C/min up to 280 °C, hold for 15 min and finally 11 °C/min up to 300 °C, hold for 5 min. The carrier gas used was helium, at a flow rate of 1.0 mL/min. The temperature of the injector and transfer line was 280 °C with an injection volume of 2 µL and a split ratio of 1:50. The scan time was 75 min and the acquisition range mass spectra *m*/*z* 29--400. The identification relied on the combination of linear retention indices (RIs) and mass spectra (MS) with those stored in Adams, FFNSC2 and NIST17 libraries \[[@B21-antibiotics-09-00029],[@B22-antibiotics-09-00029],[@B23-antibiotics-09-00029]\]. Relative peak area percentages were extracted for each peak from the total area in the chromatograms without using correction factors.

4.4. Bacterial Strains {#sec4dot4-antibiotics-09-00029}
----------------------

The *E. coli* strains were isolated at the microbiology laboratory of Sétif University Hospital, Algeria from patients with urinary tract infections. Identification of the strains was performed by matrix-assisted laser desorption ionization time of flight Mass Spectrometry (MALDI-TOF MS) (Bruker Daltonics, Bremen, Germany). Four *E. coli* strains (*E. coli* 734, 854, 292, 229) were resistant to 3rd and 4th generation cephalosporins and produce extended spectrum β-lactamase (ESBL) enzymes \[[@B1-antibiotics-09-00029]\]. One strain (*E. coli* 667) was resistant to both cephalosporins and carbapenems (ertapenem) by producing ESBL and OXA-48 enzymes \[[@B1-antibiotics-09-00029]\], and one other strain (*E. coli* 115) was resistant to colistin, which is considered as the last resort treatment of carbapenem resistant *Enterobacteriaceae* \[[@B2-antibiotics-09-00029]\]. Two reference strains (*E. coli* ATCC 25922 and *E. coli* J-53) were also used for the antibacterial tests.

4.5. Screening for Antibacterial Activity {#sec4dot5-antibiotics-09-00029}
-----------------------------------------

The disc-diffusion method was used to investigate the potential antibacterial activity of the EOs against six uropathogenic MDR and two reference susceptible *E. coli* strains. A culture of 0.5 McFarland from each strain was seeded on Muller Hinton (MH) agar plates using a sterile swab. Sterile blank paper discs of 6 mm diameter (Becton Dickinson, Le Pont de Claix, France) were gently pressed onto the MH agar plates. EOs (15 µL) and pure components (carvacrol, thymol, *p*-cymene and *γ*-terpinene, Sigma-Aldrich, Milan, Italy) (15 µL/14 mg) were pipetted onto the blank discs and each EO was tested pure and at two other dilutions (1/2 and 1/10) in DMSO. Blank discs impregnated with DMSO and discs of gentamycin (15 µg; SIRScan Discs, i2a, Montpellier, France) were used as negative and positive controls, respectively. Plates were incubated for 18--24 h at 37  °C and the diameter of the inhibition zones was measured. According to Ponce et al. \[[@B24-antibiotics-09-00029]\], sensitivity was classified as: not sensitive (diameter \<8 mm), sensitive (diameter of 9--14 mm), very sensitive (diameter of 15--19 mm) and extremely sensitive (diameter \>20 mm).

4.6. Determination of MIC and MBC {#sec4dot6-antibiotics-09-00029}
---------------------------------

The MIC and MBC were determined in 96-well plates (12 columns and 8 rows). For each EO, 10 different concentrations were tested (70, 35, 17.5, 8.75, 4, 2, 1, 0.5, 0.25, 0.125 mg/mL) (columns 12 to 3, respectively). Negative (MH broth and DMSO) and positive (MH broth and bacterial inoculum, without essential oils) controls were prepared for each plate in columns 1 and 2, respectively. One *E. coli* strain was tested in each row (8 strains tested from row A to H). The plates were incubated overnight at 37 °C. The MIC values corresponded to the first well of each row where no visible bacterial growth was detected. The MBC was determined from the first three wells of each row that showed no bacterial growth after plate incubation. For that, 10 µL from the corresponding wells were seeded on MacConkey agar (Becton Dickinson, Le Pont de Claix, France) plates. After overnight incubation at 37 °C, any bacterial growth was checked. The MBC values represent the concentrations from plates where no bacterial colonies were found.

4.7. Statistical Analysis {#sec4dot7-antibiotics-09-00029}
-------------------------

All experiments were performed in duplicate and data were expressed as mean values ± standard deviation (SD).

5. Conclusions {#sec5-antibiotics-09-00029}
==============

In summary, thymol, carvacrol, *γ*-terpinene and *p*-cymene were the main components found in the different *O. glandulosum* EOs, with a predomination of thymol in EOs from Sétif, Mila and M'sila and carvacrol in EOs from Bordj and El Oued. All EOs were active against all *E. coli* strains including the MDR ones. The EO from the Bordj location contained the highest amount of carvacrol (59.6%), and showed the highest antibacterial activity (diameters from 12 to 24.5 mm at dilution of 1/10). *O. glandulosum* EOs have potential use as natural antibacterial agents to treat or prevent infections (e.g., urinary tract infections) with MDR strains. The effectiveness of the *O. glandulosum* EOs has been shown to strictly depend on the content of carvacrol, thymol and *p*-cymene. Thus, where it is not possible to cultivate the plant in order to obtain active EOs, the possibility of manufacturing artificial blends containing carvacrol, thymol and *p*-cymene could be considered. Further studies are still necessary to assess the safety of these EOs for clinical use.
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antibiotics-09-00029-t001_Table 1

###### 

Chemical composition of the EOs from five populations of the Algerian endemic *O. glandulosum* Desf.

  Component ^a^                    RI Calc. ^b^   RI Lit. ^c^   EO %                          
  -------------------------------- -------------- ------------- -------- ------ ------ ------ -------
  (2*E*)-Hexenal                   846            846           ^d^ tr   \-     0.1    0.1    \-
  3-Heptanone                      883            890           tr       \-     \-     tr     \-
  α-Thujene                        918            924           1.2      1.0    0.7    0.5    0.4
  α-Pinene                         923            932           0.5      0.4    0.4    0.4    0.4
  Camphene                         936            946           tr       tr     tr     tr     \-
  Sabinene                         962            969           tr       tr     tr     \-     \-
  β-Pinene                         965            974           0.1      0.1    0.1    0.1    tr
  1-Octen-3-ol                     972            974           0.1      0.2    0.2    0.4    0.2
  3-Octanone                       982            979           tr       0.1    0.1    0.1    tr
  Myrcene                          985            988           1.4      1.2    0.8    1.0    0.7
  3-Octanol                        994            988           \-       \-     \-     tr     \-
  α-Phellandrene                   1000           1002          0.2      0.2    0.1    0.1    0.1
  δ-3-Carene                       1005           1008          tr       tr     tr     tr     \-
  α-Terpinene                      1011           1014          2.6      2.2    1.2    1.7    1.4
  *p*-Cymene                       1019           1025          9.7      10.3   8.5    13.9   11.6
  Sylvestrene                      1022           1032          0.4      0.3    0.2    0.3    0.2
  (*Z*)-β-Ocimene                  1034           1032          tr       tr     tr     tr     \-
  (*E*)-β-Ocimene                  1044           1044          tr       tr     tr     tr     \-
  *γ*-Terpinene                    1053           1054          21.8     19.4   9.8    14.2   13.4
  *cis*-Sabinene hydrate           1061           1065          tr       tr     tr     tr     \-
  (2Z)-Hexenal diethyl acetal      1079           1081          \-       tr     \-     tr     \-
  Terpinolene                      1082           1086          tr       tr     tr     tr     \-
  *p*-Cymenene                     1084           1089          \-       \-     tr     tr     \-
  *trans*-Sabinene hydrate         1093           1098          tr       tr     tr     tr     \-
  Linalool                         1097           1095          0.6      0.7    0.6    0.7    0.3
  Borneol                          1158           1165          tr       tr     0.1    0.1    tr
  Terpinen-4-ol                    1170           1174          0.3      0.2    0.3    0.4    0.1
  *p*-Cymen-8-ol                   1182           1179          tr       tr     tr     0.1    \-
  α-Terpineol                      1185           1186          0.3      0.3    0.4    0.4    0.1
  *cis*-Dihydro carvone            1192           1191          \-       \-     tr     tr     \-
  *trans*-Dihydro carvone          1200           1200          \-       \-     tr     \-     \-
  Thymol, methyl ether             1231           1232          0.1      0.1    tr     0.2    0.1
  Carvacrol, methyl ether          1240           1241          tr       tr     0.2    0.1    0.1
  Carvenone                        1258           1255          tr       \-     \-     tr     \-
  Thymol                           1295           1289          56.3     51.0   15.1   40.1   25.3
  Carvacrol                        1301           1298          2.8      10.9   59.6   23.4   45.1
  Thymol acetate                   1350           1349          tr       \-     \-     tr     \-
  Carvacrol acetate                1367           1370          \-       \-     \-     tr     \-
  (*E*)-Caryophyllene              1403           1417          1.2      0.8    0.6    0.7    0.3
  *trans-*α-Bergamotene            1424           1432          \-       \-     \-     tr     \-
  α-Humulene                       1436           1452          tr       tr     tr     tr     \-
  β-Bisabolene                     1495           1505          0.1      0.1    0.2    0.4    tr
  δ-Cadinene                       1507           1522          \-       \-     \-     tr     \-
  β-Sesquiphellandrene             1509           1521          0.2      0.2    0.3    0.1    \-
  Caryophyllene oxide              1562           1582          tr       0.1    0.1    0.2    \-
  Grouped compounds (%)                                                                       
  Monoteropene hydrocarbons                                     37.9     35.1   21.9   32.2   28.2
  Oxygenated monoterpenes                                       60.4     63.2   76.2   65.2   71.1
  Sesquiterpene hydrocarbons                                    1.4      1.1    1.2    1.3    0.3
  Oxygenated sesquiterpenes                                     tr       0.1    0.1    0.2    \-
  Others                                                        0.3      0.4    0.6    0.9    0.4
  Number of identified compounds                                37       34     37     43     21
  Total identified (%)                                          99.9     99.9   99.9   99.8   100.0

^a^ Order of components according to their elution from a HP-5MS column. ^b^ RI calc.: calculated retention index. ^c^ RI lit.: retention index reported from the literature. ^d^ tr: trace.

antibiotics-09-00029-t002_Table 2

###### 

Antibacterial activity of the EOs from five populations of the endemic Algerian *O. glandulosum* expressed as diameter inhibition zones.

  City of Collection       EO Dilution           Inhibition Diameters (mm) ± SD                                                                                       
  ------------------------ --------------------- -------------------------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------
  Sétif                    Pure                  39.6 ± 0.77                      34.8 ± 0.56   36.0 ± 1.34   31.2 ± 0.56   31.0 ± 1.41   32.1 ± 0.98   38.4 ± 0.84   38.2 ± 0.28
  1/2                      36.7 ± 0.56           33.5 ± 0.98                      35.4 ± 0.63   31.0 ± 1.34   27.9 ± 0.56   30.7 ± 1.55   37.1 ± 0.98   36.4 ± 1.97   
  1/10                     14.6 ± 0.28           15.4 ± 0.28                      15.6 ± 0.14   13.9 ± 00     12.0 ± 00     13.9 ± 0.56   17.9 ± 1.41   22.0 ± 00     
  Mila                     Pure                  38.5 ± 2.12                      36.3 ± 0.7    34.9 ± 0.56   30.6 ± 2.47   32.6 ± 1.27   30.9 ± 0.42   39.6 ± 1.97   38.4 ± 1.69
  1/2                      37.4 ± 0.84           35.4 ± 0.28                      33.1 ± 0.63   29.5 ± 0.56   30.9 ± 0.56   28.9 ± 0.98   37.4 ± 00     37.6 ± 0.28   
  1/10                     \-                    15.4 ± 0.84                      \-            \-            11.9 ± 0.42   12.4 ± 0.28   18.6 ± 00     22.8 ± 0.84   
  Bordj                    Pure                  37.7 ± 0.56                      35.5 ± 1.83   35.1 ± 0.98   32.6 ± 0.28   27.1 ± 00     26.3 ± 0.84   38.4 ± 0.84   37.6 ± 0.77
  1/2                      36.9 ± 00             34.0 ± 00                        33.7 ± 0.56   30.1 ± 2.12   24.4 ± 0.28   25.6 ± 1.41   38.2 ± 00     35.6 ± 0.28   
  1/10                     17.2 ± 1.13           16.4 ± 0.56                      17.3 ± 0.84   16.2 ± 00     12.1 ± 0.98   12.0 ± 0.28   21.8 ± 0.84   24.5 ± 1.83   
  M'sila                   Pure                  36.3 ± 1.55                      35.5 ± 00     35.1 ± 0.98   32.1 ± 0.63   28.2 ± 0.28   24.6 ± 1.27   32.0 ± 0.28   36.2 ± 0.56
  1/2                      35.9 ± 1.27           32.3 ± 0.84                      33.8 ± 00     29.9 ± 0.28   24.9 ± 0.42   23.6 ± 0.42   31.0 ± 0.28   32.4 ± 0.56   
  1/10                     15.0 ± 0.14           14.7 ± 0.28                      15.5 ± 0.84   12.9 ± 00     10.8 ± 1.13   12.8 ± 00     12.8 ± 0.84   17.3 ± 0.84   
  El Oued                  Pure                  36.8 ± 0.28                      32.6 ± 1.41   36.2 ± 00     30.4 ± 0.56   26.7 ± 0.56   26.3 ± 0.7    35.7 ± 1.55   34.6 ± 1.27
  1/2                      34.8 ± 0.84           32.3 ± 0.98                      35.4 ± 0.56   28.5 ± 1.69   24.8 ± 0.28   23.0 ± 1.55   32.4 ± 00     32.7 ± 0.56   
  1/10                     14.8 ± 00             13.1 ± 0.98                      16.7 ± 0.56   \-            \-            \-            \-            \-            
  **Pure compounds**                                                                                                                                                  
  carvacrol                Pure                  36.0 ± 00                        34.0 ± 0.7    34.5 ± 0.7    30.0 ± 00     31.5 ± 0.7    32.5 ± 0.7    36.5 ± 0.7    36.5 ± 0.7
  1/2                      30.5 ± 0.7            30.0 ± 00                        31.0 ± 00     28.5 ± 0.7    30.0 ± 00     30.5 ± 0.7    31.0 ± 00     30.5 ± 0.7    
  1/10                     28.0 ± 00             27.0 ± 00                        28.5 ± 0.7    26.0 ± 00     26.0 ± 00     27.0 ± 00     28.0 ± 00     28.0 ± 00     
  thymol                   Pure                  34.5 ± 07                        33.0 ± 00     34.0 ± 00     29.0 ± 00     30.0 ± 0.0    32.0 ± 00     35.0 ± 00     36.0 ± 00
  1/2                      30.0 ± 00             30.0 ± 00                        30.0 ± 0.7    28.0 ± 00     29.0 ± 00     30.0 ± 00     30.5 ± 07     31.0 ± 00     
  1/10                     27.0 ± 00             27..0 ± 00                       28.0 ± 0.7    26.5 ± 07     26.0 ± 00     27.0 ± 00     28.0 ± 00     28.0 ± 00     
  *p*-cymene               Pure                  14.0 ± 00                        14.0 ± 00     14.5 ± 0.7    12.0 ± 00     13.5 ± 0.7    14.0 ± 00     14.0 ± 00     14.0 ± 00
  1/2                      12.5 ± 0.7            12.0 ± 00                        11.5 ± 0.7    10.0 ± 00     10.0 ± 00     12.0 ± 00     12.0 ± 00     11.5 ± 0.7    
  1/10                     10.0 ± 00             9.0 ± 00                         10.0 ± 00     \-            \-            8.0 ± 00      10.0 ± 00     10.0 ± 00     
  *γ*-terpinene            Pure                  \-                               \-            \-            \-            \-            \-            \-            \-
  1/2                                                                                                                                                                 
  1/10                                                                                                                                                                
  carvacrol + *p*-cymene   50/50 (%) (*v*/*v*)   30.0 ± 00                        30.0 ± 00     30.0 ± 00     29.0 ± 00     30.0 ± 00     30.0 ± 00     30.5 ± 0.7    31.0 ± 00
  thymol + *p*-cymene      50/50 (%) (*v*/*v*)   30.0 ± 00                        30.0 ± 00     30.0 ± 00     28.0 ± 00     29.0 ± 00     30.0 ± 00     32.0 ± 00     31.0 ± 00
  Gentamycin (+control)                          18.7 ± 0.21                      \-            \-            17.3 ± 0.84   \-            18.6 ± 0.63   21.4 ± 0.77   22.7 ± 0.91
  DMSO (-control)                                \-                               \-            \-            \-            \-            \-            \-            \-

ESBL: extended spectrum β-lactamase, CRB: carbapenemase producer, COL R: colistin resistant, DMSO: dimethyl sulfoxide, SD: standard deviation, v: volume, (-): no activity observed.
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###### 

Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of *O. glandulosum* EOs and main active pure compounds.

  *O. glandulosum* Collection Site   MIC (MBC) mg/mL                                                                              
  ---------------------------------- ----------------- ----------- ------------ ----------- ----------- ----------- ------------- -------------
  Sétif                              1 (1)             2 (2)       2 (2)        2 (2)       2 (2)       2 (2)       1 (1)         1 (1)
  Mila                               2 (2)             2 (2)       2 (2)        2 (2)       2 (2)       2 (2)       1 (1)         2 (2)
  Bordj                              1 (2)             2 (2)       1 (1)        2 (2)       2 (2)       2 (2)       1 (1)         1 (1)
  M'sila                             1 (1)             1 (1)       1 (1)        2 (2)       1 (1)       1 (1)       1 (1)         1 (1)
  El Oued                            1 (2)             2 (2)       2 (2)        2 (2)       1 (2)       2 (2)       1 (1)         2 (2)
  Major bioactive components                                                                                                      
  carvacrol                          0.25 (0.25)       0.5 (0.5)   0.25 (0.5)   0.5 (0.5)   0.5 (0.5)   0.5 (0.5)   0.25 (0.25)   0.25 (0.25)
  thymol                             0.25 (0.25)       0.5 (0.5)   0.5 (0.5)    0.5 (0.5)   0.5 (0.5)   0.5 (0.5)   0.25 (0.25)   0.25 (0.25)
  *p*-cymene                         \>2               \>2         \>2          \>2         \>2         \>2         \>2           \>2
  Gentamycin mg/L                    2                 \>4         \>4          2           \>4         2           1             1
